CTOs on the Move

Evofem Biosciences

www.evofem.com

 
Evofem, Inc. is a privately held biotechnology company that discovers, develops and commercializes prescription and over-the-counter products in the areas of feminine care, contraception, and the prevention of sexually transmitted infections. Evofem, Inc. is committed to delivering effective, woman-controlled, rapidly reversible forms of contraception to women globally. In February 2013, Evofem entered into a strategic alliance with Woman Care Global, a nonprofit organization whose mission is to provide access to quality, affordable, women`s healthcare products through a sustainable value chain in over 100 countries, with a particular focus on under-served markets in Africa, Asia, and Latin America. Through this alliance, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.evofem.com
  • 12400 High Bluff Drive Suite 600
    San Diego, CA USA 92130
  • Phone: 858.550.1900

Executives

Name Title Contact Details

Funding

Evofem Biosciences raised $50M on 06/10/2019
Evofem Biosciences raised $25M on 10/15/2020
Evofem Biosciences raised $30M on 03/25/2021
Evofem Biosciences raised $50M on 05/18/2021

Similar Companies

sound advice audiology inc

sound advice audiology inc is a Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kalamazoo X-Ray Sales

Kalamazoo X-Ray Sales is a Portage, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedLite ID

MedLite ID is an easy-to-use, disposable medical device that enables clinicans to accurately and efficiently identify a single medication infusion line against similar infusion lines in any light setting. The ninth leading cause of medical-error deaths in the United States involves infusion line confusion, and nearly 65 percent of those cases are related to the medication infusion line. MedLite ID eliminates infusion confusion by providing indicators with built-in wireless light technology at the medication bag, connector, and to patient. Each MedLite ID device is unique to its individual medication infusion line and cuts the process of infusion line identification to mere seconds. This saves clinicians precious time while also drastically mitigating risk and reducing stress while ensuring better care and patient outcomes.

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.

Mabis DMI Healthcare

Mabis DMI Healthcare is a Waukegan, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.